YOLFTbeta
Strategic Partners A/S

Strategic Partners A/S

STRAP · CO · Healthcare / Biotechnology

570.00DKK+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close570.00
Open570.00
Day Range570.00 – 570.00
52-Week Range515.00 – 946.00
Volume7
Market Cap37.09M
P/E (TTM)22.26
Forward P/E0.00
EPS31.00
Dividend Yield0.00%
Beta0.24
50-Day Avg683.10
200-Day Avg637.60

About

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Jakob Færch Bendtsen
  • Employees1
  • HeadquartersLyskær 8A, Herlev, Denmark, 2730, Denmark
  • Websitehttps://www.strategic-partners.dk

Leadership

  • Mr. Jakob Færch BendtsenCEO & Director · b. 1978

Financials

Income Statement

Currency: DKK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----036.19M-00309.00K
Cost of Revenue-572.00K746.00K1.37M3.80M5.20M18.11M782.00K---
Gross Profit--572.00K-746.00K-1.37M-3.80M-5.20M18.08M-782.00K--309.00K
Gross Margin------49.96%---100.00%
Operating Expense-62.95M130.30M230.29M332.15M603.34M101.56M40.46M--2.75M
Operating Income-59.04M-63.52M-131.04M-231.65M-335.95M-608.53M-83.47M-41.24M-27.04M-201.00K-2.45M
Operating Margin-------230.63%----791.59%
EBITDA-58.47M-62.95M-130.27M-230.28M-334.31M-615.70M-603.91M-40.46M-12.10M-201.00K-2.45M
EBITDA Margin-------1668.59%----791.59%
Net Income-47.71M-57.94M-126.20M-229.60M-337.50M-633.25M-626.54M-110.59M-26.05M-298.00K-859.00K
Net Income Margin-------1731.11%----277.99%
R&D45.87M55.82M99.05M154.95M285.41M261.14M229.94M----
R&D as % of Total Revenue------635.32%----
Interest Expense4071.00K647.00K3.45M4.80M14.11M9.61M----
Interest Expense % of Total Revenue------26.54%----

Balance Sheet

Currency: DKK2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets35.56M95.35M84.95M31.94M662.82M441.35M180.75M822.49M173.23M56.83M19.31M23.56M19.54M
Total Liabilities4.02M5.97M10.81M14.43M47.12M53.10M127.78M201.97M163.89M15.85M5.07M4.31M1.15M
Total Equity31.55M89.38M74.14M17.51M615.70M388.25M52.97M620.52M9.34M40.97M14.24M19.25M18.39M
Cash25.73M78.16M68.02M14.35M631.74M394.71M123.59M726.93M102.25M38.92M11.27M3.89M394.00K
Total Debt1.00K245.00K245.00K---77.11M70.71M39.97M----
Net Debt-25.73M-77.92M-67.77M-14.35M-631.74M-394.71M-46.48M-656.22M-62.29M-38.92M-11.27M-3.89M-394.00K

Cash Flow

Currency: DKK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-36.44M-46.41M-54.73M-95.43M-234.76M-326.82M-539.08M-602.57M-104.52M-20.02M-3.36M-2.14M
Investing Cash Flow-558.00K-495.00K-238.00K-1.49M-2.35M-3.29M-5.10M46.00K90.35M-6.94M-9.33M-1.36M
Financing Cash Flow89.42M85.75M1.30M714.30M-58.94M1.16B-30.34M-35.08M-685.00K5.31M-
Capital Expenditure558.00K495.00K238.00K1.49M2.35M3.29M5.10M994.00K13.43M000
Free Cash Flow-37.00M-46.91M-54.97M-96.92M-237.11M-330.10M-544.18M-603.57M-117.94M-20.02K-3.36M-2.14M
FCF to OCF101.53%101.07%100.43%101.56%101.00%101.01%100.95%100.16%112.85%0.10%100.00%100.00%

Key Statistics & Ratios

Market Cap37.09M
Enterprise Value17.87M
Trailing P/E22.26
Forward P/E0.00
Price / Sales122.00
Price / Book1.77
EPS31.00
Book Value465.21
Revenue (TTM)304.00K
Gross Profit (TTM)304.00K
Profit Margin443.09%
Operating Margin-927.00%
Return on Equity7.19%
Return on Assets-6.36%
Shares Outstanding53.75K
Shares Float4.41K
Beta0.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 6, 20231:1000